Diabetes Patient Advocacy Coalition to Host Virtual Advocacy Forum for New Jersey Patients with Diabetes Highlighting Policy Issues Impacting Patients at the State Level 

Forum to include perspectives from NJ General Assembly members and policy experts

WHAT:             The Diabetes Patient Advocacy Coalition (DPAC) will host a virtual advocacy forum to address issues and policy decisions impacting patients with diabetes in the State of New Jersey. Policy experts and legislative leaders will discuss active bills currently being worked on in Trenton, hot topics on diabetes policy, and other key issues impacting patients living with diabetes in the state.

The forum will include a panel discussion featuring New Jersey General Assembly members Herb Conaway (D-07) and Daniel Benson (D-14) to give a state specific and legislative perspective on the issues.

DPAC’s advocacy forums are designed to engage the diabetes community while educating advocates on diabetes related issues in their state, their state’s legislative process, and providing tools and resources for effective advocacy.

WHEN: Friday, March 19, 2021

11:00 AM – 12:30PM ET

FORMAT:  Zoom, On the Record

RSVP:  Credentialed members of the media and members of the community interested in attending the virtual forum can register HERE.

WHO: George Huntley – CEO, Diabetes Leadership Council and Diabetes Patient Advocacy Coalition

Stewart Perry – Chairman, Diabetes Leadership Council and Vice Chairman, Diabetes Patient Advocacy Coalition

Julie Babbage – Executive Director, Diabetes Patient Advocacy Coalition

Edward Hawthorne – Board Member, Diabetes Leadership Council

Asm. Herb Conaway (D-07)

Asm. Daniel Benson (D-14)

About Diabetes Patient Advocacy Coalition (DPAC) The Diabetes Patient Advocacy Coalition (DPAC) a 501(c)(4) non-partisan organization amplifying diabetes patient voice through an alliance of people with diabetes, caregivers, patient advocates, health professionals, disease organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of people with diabetes. DPAC seeks to ensure the safety and quality of medications, devices, and services; and access to care for all 30.3 million Americans with diabetes.